Malignant biliary obstruction: Distal

ERCP

Volumn , Issue , 2008, Pages 287-298

  Alsulaiman, Raed M ^a   Barkun, Alan ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882549359     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4271-6.50032-0     Document Type: Chapter

References (75)

1. Shaib Y, El-Serag HB The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24:115-125.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8-29.
3. Ghadirian P, Lynch HT, Krewski D Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003, 27:87-93.
4. Villeneuve PJ, Johnson KC, Hanley AJ, et al. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 2000, 9:49-58.
5. Okuda K, Nakanuma Y, Miyazaki M Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002, 17:1049-1055.
6. Piehler JM, Crichlow RW Primary carcinoma of the gallbladder. Surg Gynecol Obstet 1978, 147:929-942.
7. Chijiiwa K, Kimura H, Tanaka M Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg 1995, 80:61-64.
8. Nix GA, Dubbelman C, Wilson JH, et al. Prognostic implications of tumor diameter in carcinoma of the head of the pancreas. Cancer 1991, 67:529-535.
9. Irie H, Honda H, Shinozaki K, et al. MR imaging of ampullary carcinomas. J Comput Assist Tomogr 2002, 26:711-717.
10. Mortele KJ, Ji H, Ros PR CT and magnetic resonance imaging in pancreatic and biliary tract malignancies. Gastrointest Endosc 2002, 56:S206-S212.
11. Lopez Hanninen E, Amthauer H, Hosten N, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 2002, 224:34-41.
12. Mallery JS, Centeno BA, Hahn PF, et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002, 56:218-224.
13. Hunt GC, Faigel DO Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002, 55:232-237.
14. Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999, 50:27-33.
15. Sewnath ME, Karsten TM, Prins MH, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002, 236:17-27.
16. Isenberg G, Gouma DJ, Pisters PW The on-going debate about perioperative biliary drainage in jaundiced patients undergoing pancreaticoduodenectomy. Gastrointest Endosc 2002, 56:310-315.
17. Hawes RH Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies. Gastrointest Endosc 2002, 56:S201-S2015.
18. Moon SG, Han JK, Kim TK, et al. Biliary obstruction in metastatic disease: thin-section helical CT findings. Abdom Imaging 2003, 28:45-52.
19. Barkun J, Barkun A. Chapter 6: Jaundice. In: Wilomre D, Cheung L, Harken A, et al. (eds) American College of Surgeons ACS Surgery-principles and practice New York: Web MD, www.acssurgery.com 2003. http://www.acssurgery.com.
20. Freeman ML, Overby C Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 2003, 58:41-49.
21. Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004, 40:549-558.
22. Soehendra N, Reynders-Frederix V [Palliative biliary duct drainage. A new method for endoscopic introduction of a new drain]. Dtsch Med Wochenschr 1979, 104:206-207.
23. Ballinger AB, McHugh M, Catnach SM, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994, 35:467-470.
24. Abraham NS, Barkun JS, Barkun AN Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002, 56:835-841.
25. Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994, 81:1195-1198.
26. Martignoni ME, Wagner M, Krahenbuhl L, et al. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg 2001, 181:52-59. discussion 87.
27. Chen VK, Arguedas MR, Baron TH Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: a Monte-Carlo decision analysis. Clin Gastroenterol Hepatol 2005, 3:1229-1237.
28. Scheeres D, O'Brien W, Ponsky L, et al. Endoscopic stent configuration and bile flow rates in a variable diameter bile duct model. Surg Endosc 1990, 4:91-93.
29. van Berkel AM, van Marle J, Groen AK, et al. Mechanisms of biliary stent clogging: confocal laser scanning and scanning electron microscopy. Endoscopy 2005, 37:729-734.
30. Libby ED, Leung JW Prevention of biliary stent clogging: a clinical review. Am J Gastroenterol 1996, 91:1301-1308.
31. Speer AG, Cotton PB, MacRae KD Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc 1988, 34:412-417.
32. Kadakia SC, Starnes E Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases. Gastrointest Endosc 1992, 38:454-459.
33. Catalano MF, Geenen JE, Lehman GA, et al. "Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc 2002, 55:354-358.
34. van Berkel AM, Huibregtse IL, Bergman JJ, et al. A prospective randomized trial of Tannenbaum-type Teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction. Eur J Gastroenterol Hepatol 2004, 16:213-217.
35. Pedersen FM, Lassen AT Response. Gastrointest Endosc 2000, 51:117.
36. De Ledinghen V, Person B, Legoux JL, et al. Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial. Dig Dis Sci 2000, 45:145-150.
37. Halm U, Schiefke, Fleig WE, et al. Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. Endoscopy 2001, 33:491-494.
38. Waschke K, da Silveira E, Toubouti Y, et al. The role of plastic stents, adjuvant therapy and metal stents in distal malignant biliary obstruction. a systematic review and series of metal-analyses. American Journal of Gastroenterology 2004, 99:AB 74.
39. Chan G, Barkun J, Barkun AN, et al. The role of ciprofloxacin in prolonging polyethylene biliary stent patency: a multicenter, double-blinded effectiveness study. J Gastrointest Surg 2005, 9:481-488.
40. Tringali A, Mutignani M, Perri V, et al. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy 2003, 35:992-997.
41. Raju GS, Sud R, Elfert AA, et al. Biliary drainage by using stents without a central lumen: a pilot study. Gastrointest Endosc 2006, 63:317-320.
42. Huibregtse K, Carr-Locke DL, Cremer M, et al. Biliary stent occlusion-a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy 1992, 24:391-394.
43. Dumonceau JM, Cremer M, Auroux J, et al. A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am J Gastroenterol 2000, 95:670-676.
44. Shim CS, Lee YH, Cho YD, et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 1998, 30:345-350.
45. Shah RJ, Howell DA, Desilets DJ, Sheth SG, Parsons WG, Okolo P, Lehman GA, Sherman S, Baillie J, Branch MS, Pleskow D, Chuttani R, Bosco JJ Multicenter randomized trial of the spiral Z-stent compared with the wallstent for malignant biliary obstruction. Gastrointest Endosc 2003, 57(7):830-836.
46. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004, 53:729-734.
47. Parkdo H, Kim MH, Choi JS, Lee SS, Seo DW, Kim JH, Han J, Kim JC, Choi EK, Lee SK Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol 2006, 4(6):790-796.
48. Yoon WJ, Lee JK, Lee KH, Lee WJ, Ryu JK, Kim YT, Yoon YB A comparison of covered and uncovered wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 2006, 63(7):996-1000.
49. Nakai Y, Isayama H, Komatsu Y, et al. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc 2005, 62:742-748.
50. Suk KT, Kim HS, Kim JW, Baik SK, Kwon SO, Kim HG, Lee DH, Yoo BM, Kim JH, Moon YS, Lee DK Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc 2006, 64(4):522-529.
51. Baron T, Poterucha J Insertion and removal of covered expandable metal stents for closure of complex biliary leaks. Clinical gastroenterology and hepatology 2006, 4:381-386.
52. Davids PH, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340:1488-1492.
53. Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003, 57:178-182.
54. Moss AC, Morris E, Leyden J, MacMathuna P Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007, 33(2):213-221.
55. Soderlund C, Linder S Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006, 63(7):895-986.
56. Waschke K, da Silveira E, Toubouti Y, Rahme E, Barkun A Self-expandable metal stents confer a survival advantage in palliation of distal malignant biliary obstruction. Gastrointest Endosc 2005, 61(5):T1322.
57. Arguedas MR, Heudebert GH, Stinnett AA, et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol 2002, 97:898-904.
58. Yeoh KG, Zimmerman MJ, Cunningham JT, et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc 1999, 49:466-471.
59. Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998, 47:1-7.
60. Maire F, Hammel P, Ponsot P, Aubert A, O'Toole D, Hentic O, Levy P, Ruszniewski P Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 2006, 101(4):735-742.
61. da Silveira E, Waschke K, Barkun A, et al. Cost-effectiveness decision analysis comparing covered to uncovered self-expandable metal stents to elective or on-demand polyethylene stent changes in patients with distal biliary malignant obstruction. Gastrointest Endosc 2005, 61:AB 203.
62. Bornman PC, Harries-Jones EP, Tobias R, et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1986, 1:69-71.
63. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987, 2:57-62.
64. Pinol V, Castells A, Bordas JM, et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 2002, 225:27-34.
65. Sharma D, Bhansali M, Raina VK Surgical bypass is still relevant in the palliation of malignant obstructive jaundice. Trop Doct 2002, 32:216-219.
66. Lillemoe KD, Grosfeld JL Addition of prophylactic gastrojejunostomy to hepaticojejunostomy significantly reduces gastric outlet obstruction in people with unresectable periampullary cancer. Cancer Treat Rev 2004, 30:389-393.
67. Andersen JR, Sorensen SM, Kruse A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989, 30:1132-1135.
68. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988, 75:1166-1168.
69. Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994, 344:1655-1660.
70. Taylor MC, McLeod RS, Langer B Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl 2000, 6:302-308.
71. Martin RC, Vitale GC, Reed DN, et al. Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma. Surg Endosc 2002, 16:667-670.
72. Shore S, Raraty MG, Ghaneh P, et al. Review article: chemotherapy for pancreatic cancer. Aliment Pharmacol Ther 2003, 18:1049-1069.
73. Ducreux M, Rougier P, Pignon JP, et al. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann Oncol 2002, 13:1185-1191.
74. Heinemann V Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials. Semin Oncol 2002, 29:9-16.
75. Siersema PD, Hop WC, Dees J, et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998, 47:113-120.